105 related articles for article (PubMed ID: 8233611)
1. Glutamate rich Plasmodium falciparum antigen (GLURP).
Høgh B; Thompson R; Zakiuddin IS; Boudin C; Borre M
Parassitologia; 1993 Jul; 35 Suppl():47-50. PubMed ID: 8233611
[TBL] [Abstract][Full Text] [Related]
2. A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
Theisen M; Soe S; Brunstedt K; Follmann F; Bredmose L; Israelsen H; Madsen SM; Druilhe P
Vaccine; 2004 Mar; 22(9-10):1188-98. PubMed ID: 15003647
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of a tryptophan-rich Plasmodium falciparum antigen associated with merozoites.
Ntumngia FB; Bouyou-Akotet MK; Uhlemann AC; Mordmüller B; Kremsner PG; Kun JF
Mol Biochem Parasitol; 2004 Oct; 137(2):349-53. PubMed ID: 15383306
[No Abstract] [Full Text] [Related]
4. Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.
Theisen M; Vuust J; Gottschau A; Jepsen S; Høgh B
Clin Diagn Lab Immunol; 1995 Jan; 2(1):30-4. PubMed ID: 7719909
[TBL] [Abstract][Full Text] [Related]
5. [Sequence analyzing and genotyping of the gene encoding glutamate rich protein of geographically different Plasmodium falciparum isolates obtained from different malaria endemic areas].
Zhu XP; Zhang XM; Zhou L; Gao X
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2000; 18(1):1-4. PubMed ID: 12567458
[TBL] [Abstract][Full Text] [Related]
6. A novel 70-kDa Triton X-114-soluble antigen of Plasmodium falciparum that contains interspecies-conserved epitopes.
Ma HW; Ray P; Dhanda V; Das PK; Paliwal S; Sahoo N; Patra KP; Das LK; Singh B; Kironde FA
Exp Parasitol; 1996 Aug; 83(3):322-34. PubMed ID: 8823249
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV; Biswas S; Pillai CR; Saxena RK
Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
[TBL] [Abstract][Full Text] [Related]
9. Primary structure and localization of a conserved immunogenic Plasmodium falciparum glutamate rich protein (GLURP) expressed in both the preerythrocytic and erythrocytic stages of the vertebrate life cycle.
Borre MB; Dziegiel M; Høgh B; Petersen E; Rieneck K; Riley E; Meis JF; Aikawa M; Nakamura K; Harada M
Mol Biochem Parasitol; 1991 Nov; 49(1):119-31. PubMed ID: 1775153
[TBL] [Abstract][Full Text] [Related]
10. Parasite antigen-specific interleukin-10 and antibody reponses predict accelerated parasite clearance in Plasmodium falciparum malaria.
Luty AJ; Lell B; Schmidt-Ott R; Lehman LG; Luckner D; Greve B; Matousek P; Herbich K; Schmid D; Ulbert S; Migot-Nabias F; Dubois B; Deloron P; Kremsner PG
Eur Cytokine Netw; 1998 Dec; 9(4):639-46. PubMed ID: 9889408
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-rich protein (GLURP) induces antibodies that inhibit in vitro growth of Plasmodium falciparum in a phase 1 malaria vaccine trial.
Hermsen CC; Verhage DF; Telgt DS; Teelen K; Bousema JT; Roestenberg M; Bolad A; Berzins K; Corradin G; Leroy O; Theisen M; Sauerwein RW
Vaccine; 2007 Apr; 25(15):2930-40. PubMed ID: 16914240
[TBL] [Abstract][Full Text] [Related]
12. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1.
Cortés A; Mellombo M; Masciantonio R; Murphy VJ; Reeder JC; Anders RF
Infect Immun; 2005 Jan; 73(1):422-30. PubMed ID: 15618180
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
14. Distribution of IgG subclass antibodies specific for Plasmodium falciparum glutamate-rich-protein molecule in sickle cell trait children with asymptomatic infections.
Matondo Maya DW; Mavoungou E; Deloron P; Theisen M; Ntoumi F
Exp Parasitol; 2006 Feb; 112(2):92-8. PubMed ID: 16356497
[TBL] [Abstract][Full Text] [Related]
15. Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2.
Felger I; Steiger S; Hatz C; Smith T; Beck HP
Parasite Immunol; 2003; 25(11-12):531-43. PubMed ID: 15053774
[TBL] [Abstract][Full Text] [Related]
16. Expression and immunogenicity of tripeptide repeat region on P190 of Plasmodium falciparum.
Pan W; Yang S; Deng H; Lu D
Chin J Biotechnol; 1994; 10(4):249-56. PubMed ID: 7780021
[TBL] [Abstract][Full Text] [Related]
17. Antibody response profiles induced by Plasmodium falciparum glutamate-rich protein in naturally exposed individuals from a Brazilian area endemic for malaria.
Pratt-Riccio LR; Lima-Junior JC; Carvalho LJ; Theisen M; Espíndola-Mendes EC; Santos F; Oliveira-Ferreira J; Goldberg AC; Daniel-Ribeiro CT; Banic DM
Am J Trop Med Hyg; 2005 Dec; 73(6):1096-103. PubMed ID: 16354819
[TBL] [Abstract][Full Text] [Related]
18. Cytophilic antibodies to Plasmodium falciparum glutamate rich protein are associated with malaria protection in an area of holoendemic transmission.
Lusingu JP; Vestergaard LS; Alifrangis M; Mmbando BP; Theisen M; Kitua AY; Lemnge MM; Theander TG
Malar J; 2005 Sep; 4():48. PubMed ID: 16194274
[TBL] [Abstract][Full Text] [Related]
19. Correlation of high levels of antibodies to multiple pre-erythrocytic Plasmodium falciparum antigens and protection from infection.
John CC; Moormann AM; Pregibon DC; Sumba PO; McHugh MM; Narum DL; Lanar DE; Schluchter MD; Kazura JW
Am J Trop Med Hyg; 2005 Jul; 73(1):222-8. PubMed ID: 16014863
[TBL] [Abstract][Full Text] [Related]
20. Identification of a conserved region of Plasmodium falciparum MSP3 targeted by biologically active antibodies to improve vaccine design.
Singh S; Soe S; Mejia JP; Roussilhon C; Theisen M; Corradin G; Druilhe P
J Infect Dis; 2004 Sep; 190(5):1010-8. PubMed ID: 15295710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
